Jonathan R. Seckl
Endocrinology Unit
BHF Centre for Cardiovascular Science
Queens Medical Research Institute
47 Little France Crescent
United Kingdom
Name/email consistency: high
- Minireview: stress-related psychiatric disorders with low cortisol levels: a metabolic hypothesis. Yehuda, R., Seckl, J. Endocrinology (2011)
- Glucocorticoids, developmental 'programming' and the risk of affective dysfunction. Seckl, J.R. Prog. Brain Res. (2008)
- Glucocorticoid "programming" and PTSD risk. Seckl, J.R., Meaney, M.J. Ann. N. Y. Acad. Sci. (2006)
- 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Seckl, J.R., Walker, B.R. Trends Endocrinol. Metab. (2004)
- 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Seckl, J.R. Curr. Opin. Pharmacol (2004)
- Prenatal glucocorticoids and long-term programming. Seckl, J.R. Eur. J. Endocrinol. (2004)
- Glucocorticoid programming. Seckl, J.R., Meaney, M.J. Ann. N. Y. Acad. Sci. (2004)
- 11Beta-hydroxysteroid dehydrogenases: a novel control of glucocorticoid action in the brain. Seckl, J.R., Yau, J., Holmes, M. Endocr. Res. (2002)
- Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Seckl, J.R., Walker, B.R. Endocrinology (2001)
- Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms. Seckl, J.R. Mol. Cell. Endocrinol. (2001)
- Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Seckl, J.R., Cleasby, M., Nyirenda, M.J. Kidney Int. (2000)
- Physiologic programming of the fetus. Seckl, J.R. Clin. Perinatol (1998)
- 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?. Seckl, J.R. Front. Neuroendocrinol (1997)
- Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system. Seckl, J.R., Chapman, K.E. Eur. J. Biochem. (1997)